SAR of a novel 'Anthranilamide Like' series of VEGFR-2, multi protein kinase inhibitors for the treatment of cancer

Novel series of anthranilamide type molecules that are active as inhibitors of B-RAF, c-KIT, and VEGFR-2 were identified.